Advance and disseminate your research in tuberculosis, malaria, Chagas disease, and leishmaniasis through the Open Lab Cofund Fellowship Program, partially funded by the European Commission through its FP7 Marie Curie co-funding program.
With access to GSK drug discovery expertise and world-class facilities, there is no better place to advance drug discovery to fight these debilitating diseases.
If you have an innovative approach to address them, we want to hear your proposal.
Applications are due February 4, 2015. See additional information in the "Collaborate with us" section.